The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report
Open accessAbstract
BACKGROUND: Until recently, lung transplantation was not considered in patients with human immunodeficiency virus (HIV). HIV seropositive patients with suppressed viral loads can now expect long-term survival with the advent of highly active antiretroviral therapies (HAART); however, HIV remains a relative contraindication to lung transplantation. We describe, to our knowledge, the first HIV seropositive lung transplant recipient in Canada. We also review the literature of previously reported cases of solid-organ transplantation in patients with HIV with a focus on immunosuppression considerations. CASE PRESENTATION: A 48-year old man received a bilateral lung transplant for a diagnosis of desquamative interstitial pneumonia (DIP) attributed to cigarette and cannabis smoking. His control of HIV infection pre-transplant was excellent on HAART, and he had no other contraindications to lung transplantation. The patient underwent bilateral lung transplantation using basiliximab, methylprednisolone, and mycophenolate mofetil (MMF) as induction immunosuppression. He was maintained on MMF, prednisone, and tacrolimus thereafter, and restarted his HAART regimen immediately post-operatively. His post-transplant course was complicated by Grade A1 minimal acute cellular rejection, as well as an enterovirus/rhinovirus graft infection. Despite these complications, his functional status and control of HIV infection remain excellent 24 months post-transplant. CONCLUSIONS: Our patient is one of only several HIV seropositive lung transplant recipients reported globally. With growing acceptance of transplantation in this population, there is a need for clarification of prognosis post-transplantation, as well as optimal immunosuppression regimens for these patients. This case report adds to the recent literature that suggests HIV seropositivity should not be considered a contraindication to lung transplantation, and that post-transplant patients with HIV can be managed safely with basiliximab, tacrolimus, MMF and prednisone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Case series have demonstrated comparable 1-year and 5-year survival for HIV-infected lung transplant recipients with CD4+ lymphocyte counts above 200/mm3 and HIV viral loads below 20 copies/ml.(81–85)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mycophenolate mofetil and its mechanisms of action
Allison, A. C., & Eugui, E. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00188-0 · Cited by 1,433
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
Chambers, D. C., Yusen, R. D., Cherikh, W. S., Goldfarb, S. B., Kucheryavaya, A. Y., Khusch, K., Levvey, B. J., Lund, L. H., Meiser, B., Rossano, J. W., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.016 · Cited by 1,045
Lund, L. H., Khush, K. K., Cherikh, W. S., Goldfarb, S., Kucheryavaya, A. Y., Levvey, B. J., Meiser, B., Rossano, J. W., Chambers, D. C., Yusen, R. D., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.019 · Cited by 805 · cited 1×
“Of the 5 patients who received transplantation more than 3 years ago, 4 have achieved 3-year survival, which is a comparable outcome to non-HIV seropositive patients [4, 10].”
ResultThe Mechanism of Action of Cyclosporin A and FK506
Ho, S., Clipstone, N., Timmermann, L., Northrop, J., Graef, I., Fiorentino, D., Nourse, J., & Crabtree, G. R. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0140 · Cited by 677
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
Tocci, M. J., Matkovich, D. A., Collier, K. A., Kwok, P., Dumont, F., Lin, S., Degudicibus, S., Siekierka, J. J., Chin, J., & Hutchinson, N. I. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.2.718 · Cited by 662
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Stock, P. G., Barin, B., Murphy, B., Hanto, D., Diego, J. M., Light, J., Davis, C., Blumberg, E., Simon, D., Subramanian, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001197 · Cited by 531
Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate Mofetil
Allison, A. C., & Eugui, E. M. (1993) · Immunological Reviews · doi:10.1111/j.1600-065x.1993.tb00652.x · Cited by 384
Manipulating Immune Responses with Immunosuppressive Agents that Target NFAT
Kiani, A., Rao, A., & Aramburu, J. (2000) · Immunity · doi:10.1016/s1074-7613(00)80188-0 · Cited by 281
HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year Outcomes
Roland, M. E., Barin, B., Carlson, L., Frassetto, L. A., Terrault, N. A., Hirose, R., Freise, C. E., Benet, L. Z., Ascher, N. L., Roberts, J. P., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02061.x · Cited by 247
Research works printed but not linked: 1
- Koval C, Malinis M, Mueller N, Krisl J, Hannan M, Grossi P, et al. Heart and lung transplantation outcomes in HIV-positive recipients. HOBOKEN: WILEY; 2018.
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Smoking-Related Interstitial Lung Diseases
Alarcón-Calderón, A., Vassallo, R., Yi, E. S., & Ryu, J. H. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2023.01.007 · Cited by 16
Lung transplantation in HIV seropositive recipients: An analysis of the UNOS registry
Donohue, J. K., Chan, E. G., Clifford, S., Ryan, J. P., Furukawa, M., Haidar, G., Bertani, A., Hage, C. A., & Sánchez, P. G. (2024) · Clinical Transplantation · doi:10.1111/ctr.15246 · Cited by 13
Organ transplantation in persons with HIV
Kumar, R. N., & Stosor, V. (2020) · AIDS · doi:10.1097/qad.0000000000002518 · Cited by 12
Lung Transplantation for People Living With HIV: Promising Mid-term Outcomes
Ralphs, A. S., Anderson, S. T., Langlais, B., D’Cunha, J., & dos Santos, P. R. (2023) · Transplantation · doi:10.1097/tp.0000000000004861 · Cited by 9
Metadata
- Authors
- Ong, S., Levy, R. D., Yee, J., Partovi, N., Churg, A., Roméo, P., Chalaoui, J., Nador, R., Wright, A., Manganas, H., & Ryerson, C. J.
- Affiliations
- University of British Columbia (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- St. Paul's Hospital (CA)
- Corresponding author
- Ryerson, Christopher J
- Venue
- BMC Pulmonary Medicine
- Published
- 2018-10-16
- Volume
- 18
- Issue
- 1
- Pages
- 162-162
- ISSN
- 1471-2466 (ISSN-L)
- PMC
- PMC6191892
- OpenAlex
- W2897505322
- Semantic Scholar
- 9b9e0d264d3b1623c15fb47ed6bde71f36ee83de
- Cited by
- 18
- References
- 42
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 6 · 2019: 1
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Pulmonary Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Open Collections
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- lung transplantation, HIV seropositivity, desquamative interstitial pneumonia, highly active antiretroviral therapy, immunosuppression, tacrolimus, mycophenolate mofetil, basiliximab, acute cellular rejection, graft infection, contraindications to transplantation
- MeSH terms
- Canada, Graft Rejection, HIV Seropositivity, Humans, Immunosuppressive Agents, Male, Middle Aged, Tomography, X-Ray Computed, Lung Transplantation, Lung Diseases, Interstitial, Antiretroviral Therapy, Highly Active, Genetic Diseases, Inborn
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report. https://app.cochat.ai/papers/10.1186/s12890-018-0727-0
- The paper
- Ong, S., Levy, R. D., Yee, J., Partovi, N., Churg, A., Roméo, P., Chalaoui, J., Nador, R., Wright, A., Manganas, H., & Ryerson, C. J. (2018). Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-018-0727-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.